drugset / Trial / NCT02649621

The Improvement of Limbal Stem Cell Deficiency (LSCD) in Unilateral Stem Cell Damage by Amniotic Membrane Extract Eye Drop (AMEED)

NCT02649621

Phase 1 Completed 10 enrolled Royan Institute
NaSingle-groupOpen-labelTreatment

Summary

Corneal epithelial cells and limbal stem cells (LSC) are located in the limbus basal epithelium that are necessary for repair of corneal. About patients with deficient or absence of this area has been proposed various treatments such as limbal stem cell transplantation. This study is a prospective clinical trial to compare the improvement of limbal stem cell deficiency (LSCD) in vivo by using of Amniotic Membrane Extract Eye Drop (AMEED).

Timeline

Start
2011-08
Primary completion
2012-03
Completion
2012-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Amniotic Membrane Extract Unknown Other